PetCaseFinder

Peer-reviewed veterinary case report

Hollow Cavity CaO<sub>2</sub> @Polydopamine Nanocomposites for pH-Responsive Ca<sup>2+</sup> -Enhanced Efficient Mild Hyperthermia in the NIR-II Region.

Year:
2024
Authors:
Wang Y et al.
Affiliation:
College of Chemistry · China

Abstract

Second near-infrared (NIR-II) mild photothermal therapy with higher tissue penetration depth and less damage to healthy tissues is emerging as an attractive antitumor modality, but its therapeutic efficiency is dramatically suppressed by the resistance of heat shock proteins (HSPs). As a widely explored photothermal agent, the application of polydopamine (PDA) in the NIR-II region is hampered by low photothermal conversion efficiency (PCE). Herein, its PCE in the NIR-II region is improved by developing novel hollow cavity CaO<sub>2</sub> @PDA nanocomposites through chelation-induced diffusion of inner core Ca<sup>2+</sup> to the shell PDA to facilitate multiple reflections of laser in the cavity. Upon pH-responsive degradation of CaO<sub>2</sub> , its structure is transformed into a stacked "nano-mesh" with excellent light absorption and an enlarged effective irradiation area. Overloading of Ca<sup>2+</sup> ions not only induces downregulation of HSPs but also enhances interference of light on membrane potential, which further aggravate mitochondrial dysfunction and reduce the thermotolerance of tumor cells, promoting efficient mild hyperthermia of PDA in the NIR-II region.

Find similar cases for your pet

PetCaseFinder finds other peer-reviewed reports of pets with the same symptoms, plus a plain-English summary of what was tried across them.

Search related cases →

Original publication: https://europepmc.org/article/MED/37992213